Rectovaginal Fistula Market Driven by Surgical Innovation and Rising Incidence of Post-Childbirth Complications
The Rectovaginal Fistula (RVF) Market is characterized by a high need for specialized surgical and medical interventions to treat this debilitating abnormal connection between the rectum and the vagina. The most common cause of RVF is obstetric trauma—complications arising from childbirth injuries, such as third- or fourth-degree lacerations and improperly healed episiotomies. Other significant causes include complications from abdominal or pelvic surgeries, inflammatory bowel diseases like Crohn's disease, radiation therapy for pelvic cancers, and infectious processes. The condition results in the involuntary passage of gas and/or stool through the vagina, leading to severe discomfort, infection risk, emotional distress, and a profound negative impact on a woman's quality of life, which underscores the immediate need for effective treatment. While small, simple fistulas may sometimes be managed conservatively with antibiotics and supportive care, the vast majority of RVFs necessitate…